Advertisement

Related Videos

Deborah Collyar: What's In It for Patients?

Clifford A. Hudis, MD: Are Cancer Drug Prices in the U.S. the Problem or the Symptom?

David T. Rubin, MD, on Biosimilars for Inflammatory Bowel Disease

Kelvin Chan, MD, FRCPC, MSc, PhD, on Opportunities to Optimize Cancer Drug Policies: The Canadian Perspective

Russell Szmulewitz, MD, on Alternative Dosing of Abiraterone in Prostate Cancer: Pharmacoeconomic Proof of Concept

Advertisement

Advertisement




Sep
30
Today In Oncology
Cleveland Clinic to Host Second Annual AI Summit for Health-Care Professionals
Cleveland Clinic President Discusses AI Summit for Health-Care Professionals
AI’s Evolving Role in Clinical Care Enterprise-Wide
Long-Term Disease Control From SBRT Equal to Surgery in Localized Prostate Cancer
Cancer Statistics 2026: What Every Medical Oncologist Should Know
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo